RBF Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $838K | Hold |
50,000
| – | – | 0.04% | 328 |
|
|
2025
Q1 | $769K | Hold |
50,000
| – | – | 0.05% | 315 |
|
|
2024
Q4 | $1.1M | Sell |
50,000
-40,000
| -44% | -$882K | 0.06% | 275 |
|
|
2024
Q3 | $1.62M | Hold |
90,000
| – | – | 0.08% | 229 |
|
|
2024
Q2 | $1.46M | Sell |
90,000
-10,000
| -10% | -$163K | 0.08% | 217 |
|
|
2024
Q1 | $1.41M | Buy |
+100,000
| New | +$1.41M | 0.08% | 244 |
|
|
2022
Q4 | – | Sell |
-70,000
| Closed | -$565K | – | 574 |
|
|
2022
Q3 | $565K | Buy |
+70,000
| New | +$565K | 0.05% | 303 |
|
|
2020
Q4 | – | Sell |
-40,000
| Closed | -$360K | – | 408 |
|
|
2020
Q3 | $360K | Buy |
+40,000
| New | +$360K | 0.04% | 270 |
|